Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07127185) titled 'Individualized Precision Therapy With Ceftobiprole Guided by PK/PD in Geriatric Populations' on Aug. 11.
Study Type: Observational [Patient Registry]
Primary Sponsor: Chinese PLA General Hospital
Condition:
Ceftobiprole
Intervention:
Diagnostic Test: LS/MS
Recruitment Status: Not recruiting
Date of First Enrollment: August 10, 2025
Target Sample Size: 150
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07127185
Published by HT Digital Content Services with permission from Health Daily Digest....